TTUHSC Receives Approval for First Pediatric Hematology/Oncology Fellowship Program

The Pediatric Hematology/Oncology Fellowship will be a 3-year training program
The Texas Tech University Health Sciences Center (TTUHSC) received approval and accreditation from the Accreditation Council of Graduate Medical Education (ACGME) for a Pediatric Hematology/Oncology Fellowship in the Department of Pediatrics.
The fellowship will be a three-year training program that equips residency trained pediatricians with the skills and knowledge needed to care for children affected by cancer and blood disorders. In addition to the pediatric hospitalist medicine, this is the second fellowship training program to be accredited within the TTUHSC Department of Pediatrics.
According to the National Resident Matching Program (NRMP), there were 909 applicants for 638 positions offered at more than 160 U.S. hematology/oncology fellowships in 2021.

Steven L. Berk, M.D.
“Hematology/oncology fellowships are extremely competitive,” TTUHSC Executive Vice President and School of Medicine Dean Steven L. Berk, M.D., said. “This ACGME accreditation is evidence of our commitment to ensuring our residents in this field are well prepared and ready for future practice. I appreciate our department and Graduate Medical Education leadership for their vision and dedication to standing up this new fellowship program, and to our important teaching hospital partners that help fund the fellow positions.”
The objectives of the fellowship program are to provide high quality training, retain trainees in the region and enhance the existing structure and attract new faculty talent to join TTUHSC. Trainees will have the opportunity to gain clinical and research skills at both Lubbock children’s hospitals in addition to learning and applying research methods at the Cancer Center at the TTUHSC School of Medicine.
About 9,910 children in the United States under the age of 15 will be diagnosed with cancer in 2023 according to the American Cancer Society. After accidents, cancer is the second leading cause of death in children ages 1 to 14. About 1,040 children under the age of 15 are expected to die from cancer in 2023.
“This will improve our ability to provide cutting edge-care to our pediatric patient population here in Lubbock and across the vast surrounding area in West Texas and Eastern New Mexico,” Mohamed Al-Rahawan, M.D., professor of pediatrics; Division Chief of Pediatric Hematology Oncology said. “The accreditation highlights our commitment to our patients and their families to provide the best possible care.”
Related Stories
TTUHSC Professor and Surgeon Receives National Award
The American Burn Association (ABA) recently presented the prestigious Lifetime Achievement Award to TTUHSC professor and burn surgeon John A. Griswold, M.D.
Santos Named Department of Surgery Chair for TTUHSC School of Medicine in Lubbock
As the new Department of Surgery chair for the School of Medicine in Lubbock, Ariel Santos, M.D., M.P.H., seeks to elevate TTUHSC’s role as the Hub of Surgery for West Texas.
U.S. News & World Report Ranks TTUHSC Schools Among Best for 2025 Graduate School Rankings
Several graduate programs at TTUHSC have been recognized in the 2025 U.S. News & World Report Best Graduate School Rankings, reaffirming the university’s continued excellence in health sciences education and training.
Recent Stories
TTUHSC Professor and Surgeon Receives National Award
The American Burn Association (ABA) recently presented the prestigious Lifetime Achievement Award to TTUHSC professor and burn surgeon John A. Griswold, M.D.
TTUHSC Researcher Receives National Award
The AACR presented its Minority-Serving Institution Faculty Scholar in Cancer Research Award to TTUHSC Associate Professor Duke Appiah, Ph.D., MPH, at the AACR 2025 Annual Meeting in Chicago recently.
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.